WallStSmart

Emerson Electric Company (EMR)vsLaser Photonics Corporation Common Stock (LASE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Emerson Electric Company generates 219464% more annual revenue ($18.32B vs $8.34M). EMR leads profitability with a 13.4% profit margin vs -209.3%. EMR earns a higher WallStSmart Score of 59/100 (C).

EMR

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 6.5Value: 4.3Quality: 5.5
Piotroski: 5/9Altman Z: 2.57

LASE

Avoid

19

out of 100

Grade: F

Growth: 7.3Profit: 2.0Value: 6.7Quality: 4.5
Piotroski: 2/9Altman Z: -7.03
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for EMR.

LASEUndervalued (+45.8%)

Margin of Safety

+45.8%

Fair Value

$1.43

Current Price

$3.13

$1.70 discount

UndervaluedFair: $1.43Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EMR3 strengths · Avg: 8.3/10
Market CapQuality
$79.55B9/10

Large-cap with strong market position

Operating MarginProfitability
24.2%8/10

Strong operational efficiency at 24.2%

EPS GrowthGrowth
27.9%8/10

Earnings expanding 27.9% YoY

LASE2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
90.2%10/10

Revenue surging 90.2% year-over-year

Debt/EquityHealth
-1.7710/10

Conservative balance sheet, low leverage

Areas to Watch

EMR3 concerns · Avg: 4.0/10
PEG RatioValuation
1.654/10

Expensive relative to growth rate

P/E RatioValuation
32.9x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
2.9%4/10

2.9% revenue growth

LASE4 concerns · Avg: 2.5/10
Market CapQuality
$119.56M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-675.0%2/10

ROE of -675.0% — below average capital efficiency

EPS GrowthGrowth
-94.7%2/10

Earnings declined 94.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : EMR

The strongest argument for EMR centers on Market Cap, Operating Margin, EPS Growth.

Bull Case : LASE

The strongest argument for LASE centers on Revenue Growth, Debt/Equity. Revenue growth of 90.2% demonstrates continued momentum.

Bear Case : EMR

The primary concerns for EMR are PEG Ratio, P/E Ratio, Revenue Growth.

Bear Case : LASE

The primary concerns for LASE are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

EMR profiles as a value stock while LASE is a hypergrowth play — different risk/reward profiles.

LASE carries more volatility with a beta of 2.60 — expect wider price swings.

LASE is growing revenue faster at 90.2% — sustainability is the question.

EMR generates stronger free cash flow (694M), providing more financial flexibility.

Bottom Line

EMR scores higher overall (59/100 vs 19/100). LASE offers better value entry with a 45.8% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Emerson Electric Company

INDUSTRIALS · SPECIALTY INDUSTRIAL MACHINERY · USA

Emerson Electric Co. is an American multinational corporation headquartered in Ferguson, Missouri. The Fortune 500 company manufactures products and provides engineering services for a wide range of industrial, commercial, and consumer markets.

Laser Photonics Corporation Common Stock

INDUSTRIALS · SPECIALTY INDUSTRIAL MACHINERY · USA

Laser Photonics Corporation (LASE) stands at the forefront of the laser technology landscape, offering cutting-edge solutions tailored for a variety of sectors, including manufacturing, aerospace, and healthcare. With a strong commitment to research and development, the company has crafted high-performance laser systems that significantly boost efficiency and productivity for its clients. As the global demand for advanced laser technologies surges, Laser Photonics is poised for substantial growth, positioning itself as an essential player in the laser market. This robust focus on innovation and continuous product enhancement makes LASE an attractive investment opportunity for institutional investors seeking to capitalize on technological advancements and industrial evolution.

Want to dig deeper into these stocks?